Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

Targeted Protein Degradation & Induced Proximity Summit

March 25 @ 12:00 am - March 27 @ 12:00 am

Join over 450 experts at the world’s leading event on protein degradation and induced proximity, where you’ll gain insights into the latest R&D and development strategies across PROTACs, molecular glues, and novel TAC drugs.

With a strong focus on advancing therapeutic candidates towards clinical approval, this summit covers everything from foundational research to IND-filing and clinical trials. Connect with industry leaders, discover emerging trends, and explore opportunities to expand the target space. Don’t miss your chance to be part of the most comprehensive meeting in the field, designed to propel the development of degraders and modulators to the next stage.

Go to Top